Fjarde Ap-fonden’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$62.8M Buy
284,507
+29,760
+12% +$8.23M 0.3% 69
2026
Q1
$75.2M Buy
254,747
+93,270
+58% +$27.7M 0.41% 45
2025
Q4
$44.1M Buy
161,477
+36,960
+30% +$10M 0.37% 58
2025
Q3
$33.6M Buy
124,517
+6,672
+6% +$1.82M 0.29% 71
2025
Q2
$32.5M Buy
117,845
+35,700
+43% +$9.71M 0.3% 70
2025
Q1
$21.8M Sell
82,145
-23,000
-22% -$5.67M 0.26% 81
2024
Q4
$24.4M Buy
105,145
+4,400
+4% +$1.01M 0.25% 73
2024
Q3
$22.2M Buy
+100,745
New +$20.8M 0.23% 85
2024
Q1
$20.8M Buy
96,745
+2,800
+3% +$588K 0.23% 91
2023
Q4
$19.8M Sell
93,945
-12,400
-12% -$2.65M 0.25% 84
2023
Q3
$21.3M Buy
106,345
+3,500
+3% +$696K 0.28% 68
2023
Q2
$19.1M Buy
102,845
+7,300
+8% +$1.35M 0.23% 86
2023
Q1
$18.3M Sell
95,545
-1,300
-1% -$235K 0.25% 88
2022
Q4
$16.3M Sell
96,845
-16,610
-15% -$2.89M 0.23% 106
2022
Q3
$23.2M Hold
113,455
0.29% 68
2022
Q2
$23.2M Buy
113,455
+22,800
+25% +$4.83M 0.29% 68
2022
Q1
$21.6M Sell
90,655
-3,145
-3% -$739K 0.21% 89
2021
Q4
$21.4M Sell
93,800
-4,922
-5% -$1.08M 0.19% 107
2021
Q3
$19.1M Buy
98,722
+1,700
+2% +$344K 0.18% 117
2021
Q2
$20.6M Sell
97,022
-10,300
-10% -$2.17M 0.19% 110
2021
Q1
$21.9M Buy
107,322
+1,900
+2% +$374K 0.2% 102
2020
Q4
$19.2M Sell
105,422
-3,300
-3% -$561K 0.18% 114
2020
Q3
$18.2M Buy
108,722
+5,800
+6% +$977K 0.2% 100
2020
Q2
$16.7M Buy
102,922
+3,900
+4% +$699K 0.21% 102
2020
Q1
$17.1M Sell
99,022
-5,500
-5% -$1.09M 0.28% 72
2019
Q4
$21M Sell
104,522
-9,400
-8% -$1.93M 0.26% 82
2019
Q3
$24.1M Sell
113,922
-7,134
-6% -$1.49M 0.31% 68
2019
Q2
$23.5M Buy
121,056
+8,100
+7% +$1.49M 0.3% 68
2019
Q1
$18.6M Buy
112,956
+27,670
+32% +$4.89M 0.23% 88
2018
Q4
$16M Sell
85,286
-7,400
-8% -$1.37M 0.28% 73
2018
Q3
$15.8M Sell
92,686
-2,754
-3% -$464K 0.23% 94
2018
Q2
$15.6M Sell
95,440
-991
-1% -$162K 0.24% 91
2018
Q1
$15.6M Buy
96,431
+783
+0.8% +$125K 0.24% 93
2017
Q4
$14M Buy
95,648
+15,336
+19% +$2.18M 0.21% 106
2017
Q3
$10.9M Sell
80,312
-261
-0.3% -$33K 0.21% 108
2017
Q2
$10.1M Buy
80,573
+11,604
+17% +$1.39M 0.2% 111
2017
Q1
$8.19M Sell
68,969
-4,738
-6% -$570K 0.2% 116
2016
Q4
$8.5M Sell
73,707
-6,914
-9% -$769K 0.2% 115
2016
Q3
$8.43M Buy
80,621
+2,121
+3% +$221K 0.18% 124
2016
Q2
$7.65M Buy
78,500
+6,110
+8% +$577K 0.18% 128
2016
Q1
$6.95M Buy
72,390
+9,366
+15% +$852K 0.16% 142
2015
Q4
$5.89M Buy
63,024
+849
+1% +$79.9K 0.15% 151
2015
Q3
$5.77M Sell
62,175
-6,776
-10% -$644K 0.16% 143
2015
Q2
$6.42M Sell
68,951
-3,781
-5% -$353K 0.15% 151
2015
Q1
$6.89M Sell
72,732
-4,316
-6% -$400K 0.16% 144
2014
Q4
$6.98M Sell
77,048
-3,556
-4% -$301K 0.15% 156
2014
Q3
$6.45M Sell
80,604
-6,154
-7% -$464K 0.14% 172
2014
Q2
$6.16M Sell
86,758
-3,751
-4% -$264K 0.12% 188
2014
Q1
$6.7M Buy
90,509
+3,237
+4% +$244K 0.13% 178
2013
Q4
$7.07M Sell
87,272
-5,072
-5% -$397K 0.15% 155
2013
Q3
$6.82M Sell
92,344
-8,481
-8% -$625K 0.15% 158
2013
Q2
$7.66M Buy
+100,825
New +$6.61M 0.16% 140

Other funds holding CME

Fjarde Ap-fonden's CME Position: Q2 2026 in Review

Fjarde Ap-fonden increased its CME Group (CME) stake by 12% in Q2 2026, buying an estimated $8.23M and bringing the position to 284,507 shares worth $62.8M. The position accounts for 0.3% of the portfolio, ranked #69.

Fjarde Ap-fonden first reported a position in CME in Q2 2013 and has held it in 52 quarters since. The position peaked at $75.2M in Q1 2026. 1,698 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Fjarde Ap-fonden held 284,507 shares of CME Group worth $62.8M as of Q2 2026.
  • Fjarde Ap-fonden bought 29,760 CME Group shares in Q2 2026, an estimated $8.23M.
  • CME Group made up 0.3% of Fjarde Ap-fonden's portfolio in Q2 2026, its #69 holding.
  • Fjarde Ap-fonden first reported a position in CME Group in Q2 2013 and has held it in 52 quarters since.
  • Fjarde Ap-fonden's CME Group position peaked at $75.2M in Q1 2026.
  • 1,698 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Fjarde Ap-fonden's 13F filing for Q2 2026, filed 29 Jul 2026.